{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:11:27Z","timestamp":1789456287961,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.vaccine.2003.07.004","type":"journal-article","created":{"date-parts":[[2003,12,6]],"date-time":"2003-12-06T11:47:31Z","timestamp":1070711251000},"page":"422-430","source":"Crossref","is-referenced-by-count":137,"title":["Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine"],"prefix":"10.1016","volume":"22","author":[{"given":"S.F","family":"Little","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.E","family":"Ivins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.F","family":"Fellows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.M","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.W","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.P","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.07.004_BIB1","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine. Evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"Friedlander","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.vaccine.2003.07.004_BIB3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/IAI.49.2.291-297.1985","article-title":"Demonstration of a capsule plasmid in Bacillus anthracis","volume":"49","author":"Green","year":"1985","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/IAI.39.1.371-376.1983","article-title":"Evidence for plasmid-mediated toxin production in Bacillus anthracis","volume":"39","author":"Mikesell","year":"1983","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2003.07.004_BIB6","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1073\/pnas.89.21.10277","article-title":"Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin","volume":"89","author":"Klimpel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB7","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.1016\/S0021-9258(17)32036-7","article-title":"Anthrax protective antigen forms oligomers during intoxication of mammalian cells","volume":"269","author":"Milne","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/116.3.377","article-title":"The pathogenesis of the lethal effect of anthrax toxin in the rat","volume":"116","author":"Beall","year":"1966","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1099\/00221287-26-1-49","article-title":"Purification of factor I and recognition of a third factor of the anthrax toxin","volume":"26","author":"Stanley","year":"1961","journal-title":"J. Gen. Micro."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB10","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/S0021-9258(17)38364-3","article-title":"Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process","volume":"261","author":"Friedlander","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP\u2013kinase\u2013kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2003.07.004_BIB12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1574-6968.1994.tb07306.x","article-title":"Zinc content of the Bacillus anthracis lethal factor","volume":"124","author":"Kochi","year":"1994","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2958.1994.tb00500.x","article-title":"Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity","volume":"13","author":"Klimpel","year":"1994","journal-title":"Mol. Micro."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(99)01502-1","article-title":"Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS\/IFNg-induced release of NO and TNFa","volume":"462","author":"Pellizzari","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/IAI.47.1.306-310.1985","article-title":"Effects of anthrax toxin components on human neutrophils","volume":"47","author":"O\u2019Brien","year":"1985","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB16","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.58.2.303-308.1990","article-title":"Immunization against anthrax with aromatic compound-dependent (Aro\u2212) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen","volume":"58","author":"Ivins","year":"1990","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in Rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.07.004_BIB20","first-page":"691","article-title":"Pathology of experimental inhalation anthrax in the Rhesus monkey","volume":"73","author":"Fritz","year":"1995","journal-title":"Lab. Invest."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB21","first-page":"1518","article-title":"Pathology of anthrax infection in animal hosts","volume":"26","author":"Gleiser","year":"1967","journal-title":"Fed. Proc."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB22","first-page":"125","article-title":"Efficacy of a standard human anthrax vaccine against Bacillus anthacis aerosol spore challenge in Rhesus monkeys","volume":"87","author":"Ivins","year":"1996","journal-title":"Salis Med. Bull."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB23","first-page":"982","article-title":"The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation","volume":"122","author":"Zaucha","year":"1998","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB24","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.07.004_BIB25","unstructured":"Ivins B, Farchaus J, Novak J, et al. Vaccine efficacy of Bacillus anthracis protective antigen produced in prokaryotic and eukaryotic cells. In: Proceedings of the 94th Annual Meeting of American Society of Microbiology, vol. E-38; 1994. p. 150 [abstract]."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/cjm-45-1-1","article-title":"Isolation of an asporogenic (spoOA) protective antigen-producing strain of Bacillus anthracis","volume":"45","author":"Worsham","year":"1999","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1128\/AEM.64.3.982-991.1998","article-title":"Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis","volume":"64","author":"Farchaus","year":"1998","journal-title":"Appl. Environ. Micro."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB28","unstructured":"Bliss CI. Linear regression. In: Statistics in biology: statistical methods for research in the natural sciences, vol. 1. New York: McGraw-Hill; 1967. p. 152\u201385."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(89)90397-9","article-title":"Re-examination and further development of a precise and rapid dye method for measuring cell growth\/cell kill","volume":"119","author":"Hansen","year":"1989","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.vaccine.2003.07.004_BIB30","unstructured":"Pitt MLM, Ivins B, Estep JE, Farchaus J, Friedlander AM. Comparative efficacy of a recombinant protective antigen vaccine against inhalation anthrax in guinea pigs, rabbits, and Rhesus monkeys. In: Proceedings of the 96th Annual Meeting of American Society of Microbiology, vol. E-70; 1996. p. 278."},{"key":"10.1016\/j.vaccine.2003.07.004_BIB31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0264-410X(97)00268-5","article-title":"Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers","volume":"16","author":"McBride","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.07.004_BIB32","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03005814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03005814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T11:23:56Z","timestamp":1623583436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03005814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":32,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0264410X03005814"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.07.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}